Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Augmedix, Inc. AUGX
$3.74
-$0.22 (-5.92%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
150499350.00000000
-
week52high
3.95
-
week52low
1.01
-
Revenue
30933000
-
P/E TTM
-5
-
Beta
-0.61381400
-
EPS
-0.62000000
-
Last Dividend
0.00000000
-
Next Earnings Date
27 мар 2023 г. в 12:30
Описание компании
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Lake Street | Buy | 07 мар 2022 г. | |
| Maxim Group | Buy | 21 янв 2022 г. | |
| William Blair | Outperform | 01 ноя 2021 г. | |
| Benchmark | Buy | 01 ноя 2021 г. | |
| B. Riley Securities | Buy | 10 июн 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| McKesson Ventures, LLC | D | 1572432 | 2410000 | 13 дек 2022 г. |
| Ginocchio Paul | A | 118000 | 18000 | 13 дек 2022 г. |
| McKesson Ventures, LLC | D | 3982432 | 3307 | 05 окт 2022 г. |
| McKesson Ventures, LLC | D | 3985739 | 5294 | 04 окт 2022 г. |
| McKesson Ventures, LLC | D | 3991033 | 1779 | 03 окт 2022 г. |
| McKesson Ventures, LLC | D | 3992812 | 12194 | 30 сент 2022 г. |
| McKesson Ventures, LLC | D | 4005006 | 8997 | 29 сент 2022 г. |
| McKesson Ventures, LLC | D | 4014003 | 1000 | 28 сент 2022 г. |
| McKesson Ventures, LLC | D | 4015003 | 7337 | 27 сент 2022 г. |
| McKesson Ventures, LLC | D | 4022340 | 2300 | 26 сент 2022 г. |
Новостная лента
Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25
GlobeNewsWire
18 янв 2023 г. в 16:05
SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.
Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference
GlobeNewsWire
23 ноя 2022 г. в 16:05
SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Augmedix In c. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix's management will participate in one-on-one meetings with institutional analysts and investors throughout the day.
Augmedix, Inc. (AUGX) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 19:58
Augmedix, Inc. (NASDAQ:AUGX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Ji-Yon Yi - Gilmartin Group LLC Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Charlie Montang - Lake Street Capital Markets, LLC Allen Klee - Maxim Group Operator Greetings and welcome to Augmedix, Inc. Third Quarter 2022 Earnings Call.
Augmedix to Participate at the 2022 Lytham Partners Fall Investor Conference
GlobeNewsWire
15 сент 2022 г. в 16:05
SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Fall Investor Conference.
Augmedix to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
GlobeNewsWire
17 авг 2022 г. в 16:05
SAN FRANCISCO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:50 a.m. ET.